Search Within

Joachim Yahalom

  1. "Population Sciences Research Program"
Formats
  1. Journal Article (41)
  2. Meeting Abstract (38)
  3. Research Letter (2)
Groups
  1. Population Sciences Research Program (81)
  2. Radiation Oncology, Department of (81)
  3. Survivorship Research (81)
  4. Department of Medicine (70)
  5. Hematologic Malignancies, Division of (68)
  6. Center for Hematologic Malignancies (67)

More Groups

People
  1. Steven Horwitz (65)
  2. Andrew Zelenetz (61)
  3. Ariela Noy (45)
  4. Alison Moskowitz (44)
  5. David Straus (44)
  6. Paul Hamlin (44)

More People

Years
  1. 2025 (1)
  2. 2024 (4)
  3. 2023 (5)
  4. 2022 (4)
  5. 2021 (7)
  6. 2020 (7)

More Years

Publications
  1. Blood (25)
  2. Journal of Clinical Oncology (13)
  3. Journal of the National Comprehensive Cancer Network (9)
  4. Hematological Oncology (6)
  5. British Journal of Haematology (4)
  6. Blood Advances (3)

More Publications

Publishers
  1. American Society of Hematology (28)
  2. American Society of Clinical Oncology (13)
  3. Harborside Press (9)
  4. Wiley Blackwell (7)
  5. Elsevier Inc. (5)
  6. John Wiley & Sons (4)

More Publishers

Results (81)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Encouraging experience in the treatment of nasal type extra-nodal NK/T-cell lymphoma in a non-Asian population
    Journal Article

    Qi, S.; Yahalom, J.; Hsu, M.; Chelius, M.; Lunning, M.; Moskowitz, A.; Horwitz, S.
    Leukemia and Lymphoma (2016)

    Fulltext@MSK | Save
  • NCCN Guidelines® insights: Non-Hodgkin's lymphomas, version 3.2016: Featured updates to the NCCN guidelines
    Journal Article

    Horwitz, S. M.; Zelenetz, A. D.; Gordon, L. I.; Wierda, W. G.; Abramson, J. S.; Advani, R. H.; Andreadis, C. B.; Bartlett, N.; Byrd, J. C.; Fayad, L. E.; more...
    Journal of the National Comprehensive Cancer Network (2016)

    Fulltext@MSK | Save
  • Brentuximab vedotin and AVD followed by involved-site radiotherapy in early stage, unfavorable risk Hodgkin lymphoma
    Journal Article

    Kumar, A.; Casulo, C.; Yahalom, J.; Schöder, H.; Barr, P. M.; Caron, P.; Chiu, A.; Constine, L. S.; Drullinsky, P.; Friedberg, J. W.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Diffuse large B-cell lymphoma version 1.2016
    Journal Article

    Zelenetz, A. D.; Gordon, L. I.; Wierda, W. G.; Abramson, J. S.; Advani, R. H.; Andreadis, C. B.; Bartlett, N.; Byrd, J. C.; Fayad, L. E.; Fisher, R. I.; more...
    Journal of the National Comprehensive Cancer Network (2016)

    Fulltext@MSK | Save
  • Clinical features and outcome of primary pancreatic lymphoma
    Journal Article

    Sadot, E.; Yahalom, J.; Do, R. K. G.; Teruya-Feldstein, J.; Allen, P. J.; Gönen, M.; D'Angelica, M. I.; Kingham, T. P.; Jarnagin, W. R.; DeMatteo, R. P.
    Annals of Surgical Oncology (2015)

    Fulltext@MSK | Save
  • Chronic lymphocytic leukemia/small lymphocytic lymphoma, version 1.2015
    Journal Article

    Zelenetz, A. D.; Gordon, L. I.; Wierda, W. G.; Abramson, J. S.; Advani, R. H.; Andreadis, C. B.; Bartlett, N.; Byrd, J. C.; Czuczman, M. S.; Fayad, L. E.; more...
    Journal of the National Comprehensive Cancer Network (2015)

    Fulltext@MSK | Save
  • PET-adapted sequential salvage therapy with brentuximab vedotin followed by augmented ifosamide, carboplatin, and etoposide for patients with relapsed and refractory Hodgkin's lymphoma: A non-randomised, open-label, single-centre, phase 2 study
    Journal Article

    Moskowitz, A. J.; Schöder, H.; Yahalom, J.; Mccall, S. J.; Fox, S. Y.; Gerecitano, J.; Grewal, R.; Hamlin, P. A.; Horwitz, S.; Kobos, R.; more...
    Lancet Oncology (2015)

    Fulltext@MSK | Save
  • Safety and early efficacy in an ongoing pilot study of brentuximab vedotin and AVD chemotherapy followed by 30 gray involved-site radiotherapy for newly diagnosed, early stage, unfavorable risk Hodgkin lymphoma
    Meeting Abstract

    Kumar, A.; Yahalom, J.; Schoder, H.; Caron, P.; Drullinsky, P.; Gerecitano, J. F.; Hamilton, A.; Hamlin, P.; Horwitz, S. M.; Jacob, A. G.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Modified SMILE (mSMILE) is active in the treatment of extranodal natural killer/T-cell lymphoma: A single center US experience
    Meeting Abstract

    Lunning, M.; Pamer, E.; Maragulia, J.; Straus, D.; Yahalom, J.; Moskowitz, A.; Zelenetz, A. D.; Horwitz, S.
    Clinical Lymphoma, Myeloma and Leukemia (2014)

    Fulltext@MSK | Save
  • Non-Hodgkin's lymphomas, version 4.2014
    Journal Article

    Zelenetz, A. D.; Gordon, L. I.; Wierda, W. G.; Abramson, J. S.; Advani, R. H.; Andreadis, C. B.; Bartlett, N.; Byrd, J. C.; Czuczman, M. S.; Fayad, L. E.; more...
    Journal of the National Comprehensive Cancer Network (2014)

    Fulltext@MSK | Save